Introduction Ulcerative colitis (UC) is a colonic inflammatory disorder of unconfirmed aetiology. Clinical assessment involves invasive endoscopic examination with a small yet significant procedural risk, on which therapeutic decisions are made. Noninvasive biomarkers may be better tolerated and reduce procedural costs and risks. Matrix metalloproteinases (MMP) are enzymes involved in tissue remodelling; MMP are elevated in mucosa and urine of children with active UC. We measured urinary MMP activity in adult patients with UC, matched controls investigated for functional symptoms and normal healthy volunteers to evaluate as a potential biomarker of disease activity. Methods Ethical approval and informed consent were obtained. Patients with UC and age-sex matched controls, identified during outpatient assessment, were prospectively recruited and flexible sigmoidoscopy (FS) performed. Endoscopic (Sutherland) and histological (Gomes) appearance in patients with UC was graded. A group of healthy volunteers were recruited at a local University. Urine samples, snap frozen at collection in liquid nitrogen, were thawed, centrifuged, and assayed using commercially obtained fluorescein-labelled gelatinase activity kits. MMP activity was corrected for creatinine concentration. Results were expressed as median 6 IQR. Statistical tests included KruskaleWallis analysis and Spearman's correlation. Results 80 active and 16 quiescent UC patients, 77 age-sex matched controls and 22 normal healthy volunteers were compared. Urinary MMP activity in active compared with quiescent UC (p¼0.185) and in each compared with age-sex matched controls (p¼0.237, p¼0.525 respectively) was not significantly different. Exclusion of patients taking 5-aminosalicylates and corticosteroids did not alter significance. There was no correlation between urinary MMP activity and UC disease activity measured endoscopically (r¼0.09, p¼0.425) or histologically (r¼0.178, p¼0.127). Urinary MMP activity in healthy volunteers was significantly lower than patients with active UC (p<0.0001), quiescent UC (p<0.002), and controls (p<0.0001). Conclusion Contrary to previously published work, our findings suggest that urinary MMP activity, measured using fluoresceinlabelled gelatinase assay, does not discriminate between quiescent and active UC and does not correlate with UC disease activity. Significant differences noted between healthy volunteers and patients with UC were unexpected, but may reflect difference in group demographics. MMP gelatinase assays are therefore a poor non-invasive biomarker of disease activity in UC.
Introduction Ulcerative colitis (UC) is a colonic inflammatory disorder of unconfirmed aetiology. Clinical assessment involves invasive endoscopic examination with a small yet significant procedural risk, on which therapeutic decisions are made. Noninvasive biomarkers may be better tolerated and reduce procedural costs and risks. Matrix metalloproteinases (MMP) are enzymes involved in tissue remodelling; MMP are elevated in mucosa and urine of children with active UC. We measured urinary MMP activity in adult patients with UC, matched controls investigated for functional symptoms and normal healthy volunteers to evaluate as a potential biomarker of disease activity. Methods Ethical approval and informed consent were obtained. Patients with UC and age-sex matched controls, identified during outpatient assessment, were prospectively recruited and flexible sigmoidoscopy (FS) performed. Endoscopic (Sutherland) and histological (Gomes) appearance in patients with UC was graded. A group of healthy volunteers were recruited at a local University. Urine samples, snap frozen at collection in liquid nitrogen, were thawed, centrifuged, and assayed using commercially obtained fluorescein-labelled gelatinase activity kits. MMP activity was corrected for creatinine concentration. Results were expressed as median 6 IQR. Statistical tests included KruskaleWallis analysis and Spearman's correlation. Results 80 active and 16 quiescent UC patients, 77 age-sex matched controls and 22 normal healthy volunteers were compared. Urinary MMP activity in active compared with quiescent UC (p¼0.185) and in each compared with age-sex matched controls (p¼0.237, p¼0.525 respectively) was not significantly different. Exclusion of patients taking 5-aminosalicylates and corticosteroids did not alter significance. There was no correlation between urinary MMP activity and UC disease activity measured endoscopically (r¼0.09, p¼0.425) or histologically (r¼0.178, p¼0.127). Urinary MMP activity in healthy volunteers was significantly lower than patients with active UC (p<0.0001), quiescent UC (p<0.002), and controls (p<0.0001). Conclusion Contrary to previously published work, our findings suggest that urinary MMP activity, measured using fluoresceinlabelled gelatinase assay, does not discriminate between quiescent and active UC and does not correlate with UC disease activity. Significant differences noted between healthy volunteers and patients with UC were unexpected, but may reflect difference in group demographics. MMP gelatinase assays are therefore a poor non-invasive biomarker of disease activity in UC. Introduction Ulcerative colitis (UC) is a chronic inflammatory condition of the colon of unconfirmed aetiology. Microscopic examination of inflamed biopsies is characterised by progressive neutrophil infiltration and tissue destruction. There is conflicting evidence from studies on the relative roles of TNFa, IL-8, TGFb and other cytokines in UC; however, current therapy includes cytokine targeted interventions. We compared cytokine profiles of inflamed and non-inflamed mucosa in patients with distal UC, and age-sex matched controls. Methods Ethical approval was obtained. Patients were prospectively recruited from outpatients' clinics. Mucosal biopsies at flexible sigmoidoscopy (FS) were taken from UC patients within macroscopically inflamed and non-inflamed proximal mucosa, and from age-sex matched controls undergoing FS. Severity of endoscopic (Sutherland) and histological (Gomes) inflammation were recorded. Quantitative cytokine analysis for IL-4, TNFa, IL-17A, IL-8, IL-10, TGFb and IFN-g were carried out using commercially available assays on tissue homogenates prepared with protease inhibitors, corrected for total protein. Statistical comparison was by Wilcoxon signed rank pair analysis and Spearman's correlation. Results 69 active UC patients (54 paired normal/inflamed mucosa) and 69 controls were compared. Significant elevation in IL-8 (p<0.001; p<0.001) and reduction in TGFb (p<0.02; p<0.0002) with significant positive correlation of IL-8 (r2¼+0.46; p<0.01) and negative correlation of TGFb (r2¼À0.46; p<0.01) to severity of inflammation was detected in inflamed compared with non-inflamed mucosa from the same patient and compared to age-sex matched control mucosa; however, TNFa concentration was not significantly different. Comparisons of macroscopically inflamed mucosa compared with non-inflamed mucosa from the same patients also demonstrated significant reduction in concentration of IFNg (p<0.001), IL-4 (p<0.005) and IL-17A (p<0.002). No significant differences were noted between normal tissue from UC patients and external controls. Conclusion Our findings suggest that IL-8 (a neutrophil chemoattractant) is elevated and TGFb (involved in cell repair) is reduced with no change demonstrated for TNFa. Significantly lower concentration of IFNg, IL-4 and IL-17A suggests downregulation of Th1, Th2 and Th17 adaptive immune response. These findings suggest that the inflammatory response in UC may predominantly involve IL-8 mediated neutrophil infiltration and failure of TGFb mediated tissue healing, with limited evidence for the role of TNFa in mild-moderate distal UC.
